SCHEMBL8368751

SCHEMBL8368751

O=C1c2cc3c(cc2OC2CCCN12)C(=O)N1OCCC1O3

nearest known ligand 0.71

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
GRIA1 P42261 1/20 0.71

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8314975 0.88 GRIA1 (0.82) GRIA1
SCHEMBL8367567 0.84 GRIA1 (0.75) GRIA1
SCHEMBL8367555 0.84 GRIA1 (0.80) GRIA1
SCHEMBL678000 0.83 GRIA1 (1.00) GRIA1
SCHEMBL29542563 0.83 GRIA1 (1.00) GRIA1
SCHEMBL31562972 0.80 GRIA1 (0.84) GRIA1
SCHEMBL12049626 0.80 GRIA1 (0.84) GRIA1
SCHEMBL8367564 0.80 GRIA1 (0.69) GRIA1
SCHEMBL8367101 0.78 GRIA1 (0.67) GRIA1
SCHEMBL8366785 0.77 GRIA1 (0.69) GRIA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7799913-B2 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses CORTEX PHARMACEUTICALS, INC. (US) 2010-09-21 US disclosed
US-7799913-B2 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses CORTEX PHARMACEUTICALS, INC. (US) 2010-09-21 US disclosed
WO-2003045315-A2 CARBONYLBENZOXAZINE COMPOUNDS FOR ENHANCING GLUTAMATERGIC SYNAPTIC RESPONSES CORTEX PHARMACEUTICALS, INC. (US) 2003-06-05 WO disclosed